Literature DB >> 8544905

Decreases in protease nexins in Alzheimer's disease brain.

B H Choi1, R C Kim, P J Vaughan, A Lau, W E Van Nostrand, C W Cotman, D D Cunningham.   

Abstract

A marked and significant reduction of protease nexin-1 (PN-1) and PN-2/amyloid beta protein precursor (A beta PP) was observed in selected regions of Alzheimer's disease (AD) brains as compared to those of aged-matched controls. Correlative analysis indicated a relationship between PN-1 reduction and the severity of pathologic alterations. A statistically significant inverse correlation was noted between the level of PN-1 activity and the density of tau-positive dystrophic neurites in the hippocampus. In view of the ability of thrombin and PN-1 activity to regulate neurite outgrowth, it is possible that abnormal thrombin and PN-1 interactions may play a role in dystrophic neurite formation. The presence of clusters of dystrophic neurites around the capillaries suggests that blood-brain barrier (BBB) dysfunction may enhance such abnormal interactions. The decrease in PN-2/A beta PP levels in AD brains could possibly contribute to neuronal degeneration in AD in view of the ability of PN-2/A beta PP to protect neurons against the toxic effects of the A beta.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8544905     DOI: 10.1016/0197-4580(95)00060-r

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  11 in total

1.  Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities.

Authors:  F M Donovan; C J Pike; C W Cotman; D D Cunningham
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

Review 2.  Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.

Authors:  R Ramachandran; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

3.  Relationships between expression of apolipoprotein E and beta-amyloid precursor protein are altered in proximity to Alzheimer beta-amyloid plaques: potential explanations from cell culture studies.

Authors:  Steven W Barger; Kevin Mark DeWall; Ling Liu; Robert E Mrak; W Sue T Griffin
Journal:  J Neuropathol Exp Neurol       Date:  2008-08       Impact factor: 3.685

4.  Cycle on Wheels: Is APP Key to the AppBp1 Pathway?

Authors:  Y Chen; Rn Neve; H Zheng; Wts Griffin; Sw Barger; Re Mrak
Journal:  Austin Alzheimers Parkinsons Dis       Date:  2014

Review 5.  Complement in the brain.

Authors:  Robert Veerhuis; Henrietta M Nielsen; Andrea J Tenner
Journal:  Mol Immunol       Date:  2011-05-04       Impact factor: 4.407

6.  Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Authors:  Steven F Werder
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

7.  Protease-activated receptor dependent and independent signaling by kallikreins 1 and 6 in CNS neuron and astroglial cell lines.

Authors:  Alexander G Vandell; Nadya Larson; Gurunathan Laxmikanthan; Michael Panos; Sachiko I Blaber; Michael Blaber; Isobel A Scarisbrick
Journal:  J Neurochem       Date:  2008-09-06       Impact factor: 5.372

8.  Spatial RNA Sequencing Identifies Robust Markers of Vulnerable and Resistant Human Midbrain Dopamine Neurons and Their Expression in Parkinson's Disease.

Authors:  Julio Aguila; Shangli Cheng; Nigel Kee; Ming Cao; Menghan Wang; Qiaolin Deng; Eva Hedlund
Journal:  Front Mol Neurosci       Date:  2021-07-08       Impact factor: 5.639

9.  Long-term gene therapy causes transgene-specific changes in the morphology of regenerating retinal ganglion cells.

Authors:  Jennifer Rodger; Eleanor S Drummond; Mats Hellström; Donald Robertson; Alan R Harvey
Journal:  PLoS One       Date:  2012-02-08       Impact factor: 3.240

10.  The effects of trypsin on rat brain astrocyte activation.

Authors:  Masoud Fereidoni; Farzaneh Sabouni; Ali Moghimi; Shirin Hosseini
Journal:  Iran J Neurol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.